NORTHERN NEW ENGLAND ACCOUNTABLE CARE COLLABORATIVE NNEACC 1 LD 1818 WORK GROUP David Wennberg August 9, 2012.

Slides:



Advertisements
Similar presentations
CDM Registry Project Dr. Richard Lewanczuk Regional Medical Director Chronic Disease Management Capital Health.
Advertisements

DCH/Navigant Medicaid & PeachCare Strategy Report Medical Association of Georgia February 4, 2012 Cam Grayson.
Preliminary working draft; subject to change 0 BH Health Home October 18, Commission Meeting DRAFT PRELIMINARY WORKING DRAFT, SUBJECT TO CHANGE.
1 Performance Measurement Workgroup Meeting 3/17/2014 New All-Payer Model Monitoring Measures.
A Quality Focused, Financially Responsible Approach to Medicaid Reform Jeffrey W. Runge, MD, FACEP NC Medical Society Board of Directors February 11, 2015.
A Plan to Transform the Empire State’s Medicaid Program 2013 Ten State Regional Conference February 23, 2013 Jason A. Helgerson, Medicaid Director NYS.
SUPPORTING THE INTEGRATION OF COMMUNITY HEALTH WORKERS IN MINNESOTA JUNE 5, 2014 The Minnesota Accountable Health Model (SIM Minnesota)
OUR ACCOUNTABLE CARE ORGANIZATION (ACO) STRATEGY Meredith Marsh Director Health Choice Care, LLC.
NYS Health Innovation Plan and SIM Testing Grant
Truven Health Analytics State Exchanges - Data Collection & Analysis April 2014.
Key Physicians Value Driven Health Care Conrad L. Flick MD John Meier MD, MBA.
Health Line of Business Revised Health Domains January 26, 2005 Outcomes / Domains have been revised.
July 3, 2015 New HIE Capabilities Enable Breakthroughs In Connected And Coordinated Care Delivery. January 8, 2015 Charissa Fotinos.
Tracey Moorhead President and CEO May 15, 2015 No Disclosures ©AAHCM.
Key Findings : Paying for Self-Management Supports as Part of Integrated Community Health Care Systems July, 2012.
MaineHealth ACO in Context W 5 Who? What? Why? When? HoW? 1.
Developing Your ACO Strategy Mike Scribner Beth Spoto Jimmy Lewis Kathy Whitmire Michelle Madison February 4, 2011 Spoto & Associates.
National Standards for Safer Better Healthcare
1 Emerging Provider Payment Models Medical Homes and ACOs.
American Association of Colleges of Pharmacy
Discussion Topics Healthcare: Then, Now and in the Future
Creating Sustainable Organizations The Baldrige Performance Excellence Program Sherry Martin HIV Quality of Care Advisory Committee September 13, 2012.
Success Principles in Integrated Delivery System.
Outline Update on localities establishment System Integration Clinical Framework Global Budget Setting Whanau Ora Networks Next Steps Questions?
Public Employers State Purchasing Committee March 1, 2010 Denise Honzel Health Leadership Task Force.
Insight from Premier’s PACT (Partnership for Care Transformation) Collaboratives Eugene A. Kroch, PhD Premier Research Institute Measuring Progress towards.
IOWA COLLABORATIVE SAFETY NET PROVIDER NETWORK Safety Net Network Advisory Group Meeting – 11/08/2013.
Accelerating Care and Payment Innovation: The CMS Innovation Center.
Ms Rebecca Brown Deputy Director General, Department of Health
Population Health The Road to 2020 & The Path to Value Dr. Matthew Wayne Chief Medical Officer, New Health Collaborative & Summa Physicians September 16,
DRAFT – For Discussion Only HHSC IT Governance Executive Briefing Materials DRAFT April 2013.
Modernizing Clinical Communications, Analytics, and the Revenue Cycle Process in the Era of ACOs Jason Tipton, Director of Value Operations – Holston Medical.
Maine State Innovation Model (SIM) August 2, 2013.
#HASummit14 Session #32: How One ACO Is Using Analytics to Position Itself for Population Health Management and Shared Savings Pre-Session Poll Question.
September 2008 NH Multi-Stakeholder Medical Home Overview.
Population Health and the NCM Care Transformation Collaborative of R.I. NANCY MAMO, MANAGING DIRECTOR, POPULATION HEALTH ANALYTICS, BCBSRI MAY 5, 2015.
Better, Smarter, Healthier: Delivery System Reform U.S. Department of Health and Human Services 1.
Improving Patient-Centered Care in Maryland—Hospital Global Budgets
Kathy Corbiere Service Delivery and Performance Commission
Corporate Services Restructuring 31 March Introduction  The AG completed the restructuring of Corporate Services in November 2005  The restructuring.
Pharmacists’ Patient Care Process
A NEW REIMBURSEMENT STRUCTURE FOR AMERICA ADVANCED DISEASE CONCEPTS.
Safiah Mamoon HTM 520. INTRODUCTION U.S. healthcare sector– very large with fragmented care High spending for poor outcomes Care not coordinated Providers.
Maine State Innovation Model (SIM) October, 2013.
© 2015 TriZetto Corporation 2 Health TranZform™ Solutions Joel Gleason.
1 Robert Margolis, M.D. CEO, HealthCare Partners February 25, 2010 The Future Design of Accountable, Coordinated Care Organizations.
1 State of Vermont Demonstration to Integrate Care for Dual Eligible Individuals Financing Model Workgroup Meeting #1: July 26, 2011.
Carmen Francavilla, MBA, BSN, RN-BC, PCMH CCE Director Population Health Ascension/Lourdes.
OUR FOCUS FOR 2011 TO 2012 The CfWI produces quality intelligence to inform better workforce planning, that improves people’s lives.
Overview of OHIC’s Care Transformation & Payment Reform Initiatives KATHLEEN C. HITTNER, MD. HEALTH INSURANCE COMMISSIONER NOVEMBER 12 TH, 2015.
Healthx Analytics: Turning Data Into Actionable Insights
The Impact of Accountable Care Organizations in Radiology
Prospects for New Delivery Systems and Reimbursement Models
Bundled Payments: An Initiative of Payment Reform
Measuring Outputs, Preparing for Outcomes
“Next Generation of Connected Health”
FY15 High-Level Finance Goals
Alliance Complete Care Model
The Basics on GCACH Alignment from Siloed Projects to Transformation of Care August 3, 2018.
Budget and Funds Flow Committee Retreat
Making Healthcare Affordable
Johns Hopkins Medicine Innovation 2023 Strategic Plan
Performance Measurement Workgroup Meeting 3/17/2014
Omnibus Care Plan (OCP) Care Coordination System
Value Based Payments ARE in Your Future
Sandra M. Foote Senior Advisor, Chronic Care Improvement June 23, 2005
Value-Based Healthcare: The Evolving Model
Moving from Health Care to Life Care
Medicaid Collaboration
Presentation transcript:

NORTHERN NEW ENGLAND ACCOUNTABLE CARE COLLABORATIVE NNEACC 1 LD 1818 WORK GROUP David Wennberg August 9, 2012

NNEACC High cost and lower than desired quality of care has led to strong interest in new models of funding and delivering care. ACO and Value Based Care delivery have become a leading models  Establish provider organizations that effectively manages the full continuum of care  Understand full population healthcare needs and choices  Move from fragmented, non-organized care to systems of organized care  Perform measurement to ensure focus on demonstrably improving care and lowering costs  Ability to measure and improve the quality and efficiency of health care delivery  Require payment reforms  Establish target spending  Shared savings 2 THE RATIONALE

NNEACC Created to support systems through this payment model transition by:  Driving development & implementation of risk and reimbursement models  Providing common infrastructure to support delivery of accountable care  Aggregating clinical decision support and shared-decision making  Allowing for cross system quality improvement activities 3 NNEACC Mission: To provide products and services that enable providers to deliver high quality, efficient care and to support them as they move from fee for service reimbursement and volume based care to care financed by full capitation and global budgets while delivering outcomes of care based on the Triple Aim.

NNEACC  Integrates clinical information (EHR, laboratory, ADT, etc.) claims data, public health information and patient reported information  Integrates data allowing for  Population health analytics  Predictive modeling  Quality performance and benchmarking  Enhances current EHR data  Creates a patient-centric data model  Provides a “single source of truth” across all applications for all users  Transforms integrated data into actionable information 4 INFORMATION SUITE Combination of existing foundational technology and innovative analytic & reporting solutions

NNEACC  Following the Triple Aim  Better Care  Clinical quality measures  Triggers and alerts  Better Health  Patient Reported Measures  Shared decision-making risk  Lower Costs  Financial risk/Hospitalization risks  Transitions in care risks  Actuarial models 5 MODELS, ASSESSMENTS AND TRIGGERS

NNEACC  Supports and enables management of patients by Care Managers, Clinicians and Administrators  Facilitates decision support based on evidence-based medicine and best practices  Encourages cost-effective personalized care 6 NNEACC SPECIFIC TOOLS Administrative View Clinician View Care Manager View Presents patient financial risk at the population level Informs Executive users of important trends in their healthcare system Compares actual to projections Anticipates where concerns and issues will arise Detailed information on population health, patient experience and predicted cost Benchmarking data allows clinician to evaluate performance against peers Focuses efforts on patients at highest risk Monitor patient census Act on clinician orders or app recommendations Schedule follow up Distribute clinical resources View lists by risk level and priority Encourages interaction with patients and medical team

NNEACC Last NameFirst NameMRNSexAgeNext Call Date Risk Category Fin Risk % Clinical Risk Score % PCPMost Recent Encounter Most Recent Enc Date SmithJoe M577/2/12High93%87%KayER5/20/12 JonesJane F657/2/12High87%81%MannAmb1/22/12 LeeAmy F817/12/12High81%75%DrakeAmb2/21/12 ChangTerry M45No DateMed75% RicciInpt Admit2/30/11 BrownKen M62No DateMed75%74%WoodAmb12/1/11 WhitePaul M557/6/12Med74%71%AdamsAmb9/13/11 PentCal M647/2/12Med71%65%ShinER2/2/12 SantosMikey M37No DateMed65%64%ParksER3/19/12 GoldBabs F21No DateMed64%88%PellInpt Admit4/28/12 BoltSam M787/4/12Low52%51%RicciER3/24/12 Last NameFirst NameMRNSexAgeNext Call Date Risk Category Fin Risk % Clinical Risk Score % PCPMost Recent Encounter Most Recent Enc Date BoltSam M787/4/12Low52%51%RicciER3/24/12 BrownKen M62No DateMed75%74%WoodAmb12/1/11 ChangTerry M45No DateMed75% RicciInpt Admit2/30/11 GoldBabs F21No DateMed64%88%PellInpt Admit4/28/12 JonesJane F657/2/12High87%81%MannAmb1/22/12 LeeAmy F817/12/12High81%75%DrakeAmb2/21/12 PentCal M647/2/12Med71%65%ShinER2/2/12 SantosMikey M37No DateMed65%64%ParksER3/19/12 SmithJoe M577/2/12High93%87%KayER5/20/12 WhitePaul M557/6/12Med74%71%AdamsAmb9/13/11 Last NameFirst NameMRNSexAgeNext Call Date Risk Category Fin Risk % Clinical Risk Score % PCPMost Recent Encounter Most Recent Enc Date PentCal M647/2/12Med71%65%ShinER2/2/12 GoldBabs F21No DateMed64%88%PellInpt Admit4/28/12 LeeAmy F817/12/12High81%75%DrakeAmb2/21/12 SmithJoe M577/2/12High93%87%KayER5/20/12 ChangTerry M45No DateMed75% RicciInpt Admit2/30/11 BrownKen M62No DateMed75%74%WoodAmb12/1/11 JonesJane F657/2/12High87%81%MannAmb1/22/12 SantosMikey M37No DateMed65%64%ParksER3/19/12 WhitePaul M557/6/12Med74%71%AdamsAmb9/13/11 BoltSam M787/4/12Low52%51%RicciER3/24/12 Last NameFirst NameMRNSexAgeNext Call Date Risk Category Fin Risk % Clinical Risk Score % PCPMost Recent Encounter Most Recent Enc Date GoldBabs F21No DateMed64%88%PellInpt Admit4/28/12 LeeAmy F817/12/12High81%75%DrakeAmb2/21/12 JonesJane F657/2/12High87%81%MannAmb1/22/12 PentCal M647/2/12Med71%65%ShinER2/2/12 SmithJoe M577/2/12High93%87%KayER5/20/12 ChangTerry M45No DateMed75% RicciInpt Admit2/30/11 BrownKen M62No DateMed75%74%WoodAmb12/1/11 SantosMikey M37No DateMed65%64%ParksER3/19/12 WhitePaul M557/6/12Med74%71%AdamsAmb9/13/11 BoltSam M787/4/12Low52%51%RicciER3/24/12 Last NameFirst NameMRNSexAgeNext Call Date Risk Category Fin Risk % Clinical Risk Score % PCPMost Recent Encounter Most Recent Enc Date GoldBabs F21No DateMed64%88%PellInpt Admit4/28/12 SantosMikey M37No DateMed65%64%ParksER3/19/12 ChangTerry M45No DateMed75% RicciInpt Admit2/30/11 WhitePaul M557/6/12Med74%71%AdamsAmb9/13/11 SmithJoe M577/2/12High93%87%KayER5/20/12 BrownKen M62No DateMed75%74%WoodAmb12/1/11 PentCal M647/2/12Med71%65%ShinER2/2/12 JonesJane F657/2/12High87%81%MannAmb1/22/12 BoltSam M787/4/12Low52%51%RicciER3/24/12 LeeAmy F817/12/12High81%75%DrakeAmb2/21/12 Last NameFirst NameMRNSexAgeNext Call Date Risk Category Fin Risk % Clinical Risk Score % PCPMost Recent Encounter Most Recent Enc Date SmithJoe M577/2/12High93%87%KayER5/20/12 PentCal M647/2/12Med71%65%ShinER2/2/12 JonesJane F657/2/12High87%81%MannAmb1/22/12 BoltSam M787/4/12Low52%51%RicciER3/24/12 WhitePaul M557/6/12Med74%71%AdamsAmb9/13/11 LeeAmy F817/12/12High81%75%DrakeAmb2/21/12 GoldBabs F21No DateMed64%88%PellInpt Admit4/28/12 SantosMikey M37No DateMed65%64%ParksER3/19/12 ChangTerry M45No DateMed75% RicciInpt Admit2/30/11 BrownKen M62No DateMed75%74%WoodAmb12/1/11 Last NameFirst NameMRNSexAgeNext Call Date Risk Category Fin Risk % Clinical Risk Score % PCPMost Recent Encounter Most Recent Enc Date SmithJoe M577/2/12High93%87%KayER5/20/12 JonesJane F657/2/12High87%81%MannAmb1/22/12 LeeAmy F817/12/12High81%75%DrakeAmb2/21/12 PentCal M647/2/12Med71%65%ShinER2/2/12 WhitePaul M557/6/12Med74%71%AdamsAmb9/13/11 GoldBabs F21No DateMed64%88%PellInpt Admit4/28/12 SantosMikey M37No DateMed65%64%ParksER3/19/12 ChangTerry M45No DateMed75% RicciInpt Admit2/30/11 BrownKen M62No DateMed75%74%WoodAmb12/1/11 BoltSam M787/4/12Low52%51%RicciER3/24/12 Last NameFirst NameMRNSexAgeNext Call Date Risk Category Fin Risk % Clinical Risk Score % PCPMost Recent Encounter Most Recent Enc Date LeeAmy F817/12/12High81%75%DrakeAmb2/21/12 GoldBabs F21No DateMed64%88%PellInpt Admit4/28/12 PentCal M647/2/12Med71%65%ShinER2/2/12 JonesJane F657/2/12High87%81%MannAmb1/22/12 SmithJoe M577/2/12High93%87%KayER5/20/12 BrownKen M62No DateMed75%74%WoodAmb12/1/11 SantosMikey M37No DateMed65%64%ParksER3/19/12 WhitePaul M557/6/12Med74%71%AdamsAmb9/13/11 BoltSam M787/4/12Low52%51%RicciER3/24/12 ChangTerry M45No DateMed75% RicciInpt Admit2/30/11 Last NameFirst NameMRNSexAgeNext Call Date Risk Category Fin Risk % Clinical Risk Score % PCPMost Recent Encounter Most Recent Enc Date SmithJoe M577/2/12High93%87%KayER5/20/12 JonesJane F657/2/12High87%81%MannAmb1/22/12 LeeAmy F817/12/12High81%75%DrakeAmb2/21/12 ChangTerry M45No DateMed75% RicciInpt Admit2/30/11 BrownKen M62No DateMed75%74%WoodAmb12/1/11 WhitePaul M557/6/12Med74%71%AdamsAmb9/13/11 PentCal M647/2/12Med71%65%ShinER2/2/12 SantosMikey M37No DateMed65%64%ParksER3/19/12 GoldBabs F21No DateMed64%88%PellInpt Admit4/28/12 BoltSam M787/4/12Low52%51%RicciER3/24/12 Last NameFirst NameMRNSexAgeNext Call Date Risk Category Fin Risk % Clinical Risk Score % PCPMost Recent Encounter Most Recent Enc Date GoldBabs F21No DateMed64%88%PellInpt Admit4/28/12 SmithJoe M577/2/12High93%87%KayER5/20/12 JonesJane F657/2/12High87%81%MannAmb1/22/12 LeeAmy F817/12/12High81%75%DrakeAmb2/21/12 ChangTerry M45No DateMed75% RicciInpt Admit2/30/11 BrownKen M62No DateMed75%74%WoodAmb12/1/11 WhitePaul M557/6/12Med74%71%AdamsAmb9/13/11 PentCal M647/2/12Med71%65%ShinER2/2/12 SantosMikey M37No DateMed65%64%ParksER3/19/12 BoltSam M787/4/12Low52%51%RicciER3/24/12 Last NameFirst NameMRNSexAgeNext Call Date Risk Category Fin Risk % Clinical Risk Score % PCPMost Recent Encounter Most Recent Enc Date WhitePaul M557/6/12Med74%71%AdamsAmb9/13/11 LeeAmy F817/12/12High81%75%DrakeAmb2/21/12 SmithJoe M577/2/12High93%87%KayER5/20/12 JonesJane F657/2/12High87%81%MannAmb1/22/12 SantosMikey M37No DateMed65%64%ParksER3/19/12 GoldBabs F21No DateMed64%88%PellInpt Admit4/28/12 ChangTerry M45No DateMed75% RicciInpt Admit2/30/11 BoltSam M787/4/12Low52%51%RicciER3/24/12 PentCal M647/2/12Med71%65%ShinER2/2/12 BrownKen M62No DateMed75%74%WoodAmb12/1/11 Last NameFirst NameMRNSexAgeNext Call Date Risk Category Fin Risk % Clinical Risk Score % PCPMost Recent Encounter Most Recent Enc Date WhitePaul M557/6/12Med74%71%AdamsAmb9/13/11 LeeAmy F817/12/12High81%75%DrakeAmb2/21/12 JonesJane F657/2/12High87%81%MannAmb1/22/12 BrownKen M62No DateMed75%74%WoodAmb12/1/11 SmithJoe M577/2/12High93%87%KayER5/20/12 SantosMikey M37No DateMed65%64%ParksER3/19/12 BoltSam M787/4/12Low52%51%RicciER3/24/12 PentCal M647/2/12Med71%65%ShinER2/2/12 GoldBabs F21No DateMed64%88%PellInpt Admit4/28/12 ChangTerry M45No DateMed75% RicciInpt Admit2/30/11 Last NameFirst NameMRNSexAgeNext Call Date Risk Category Fin Risk % Clinical Risk Score % PCPMost Recent Enc Most Recent Enc Date SmithJoe M577/2/12High93%87%KayER5/20/12 GoldBabs F21No DateMed64%88%PellInpt Admit4/28/12 BoltSam M787/4/12Low52%51%RicciER3/24/12 SantosMikey M37No DateMed65%64%ParksER3/19/12 LeeAmy F817/12/12High81%75%DrakeAmb2/21/12 PentCal M647/2/12Med71%65%ShinER2/2/12 JonesJane F657/2/12High87%81%MannAmb1/22/12 BrownKen M62No DateMed75%74%WoodAmb12/1/11 WhitePaul M557/6/12Med74%71%AdamsAmb9/13/11 ChangTerry M45No DateMed75% RicciInpt Admit2/30/11  Allows for filtering and sorting of key data elements Northern New England Accountable Care Collaborative 7 CARE COORDINATION - SAMPLE Monday, July 16, 2012 USER: NNEACCDemo Care Coordination Provider: Practice: Care Mgt Status:Risk Contract: (All) Ricci, Stephen Wood, James Yang, Mary Patient Search (Last, First):

NNEACC  NNEACC’s goals are to meet the needs of a successful accountable care organization  Provide a health information infrastructure to manage patients and populations  Use patient risk analysis to reduce costs and improve care  Evaluate performance against targets and benchmarks  Track and evaluate innovative methods of care delivery  Provide a framework for member organizations to share approaches and results 8 SUMMARY